BioLineRx announces publication of pre-clinical results
BioLineRx, a biopharmaceutical development company, announced the publication of pre-clinical results demonstrating that BL-7010, an orally available treatment for celiac disease, reduces gluten toxicity.
BioElectronics Corp. announced the results from their acetaminophen comparison study will be released on November 16th following the close of market.